FTO and Alzheimer disease: In the brain of amyloid precursor protein (APP)/presenilin-1 (PS1) (APP/PS1) transgenic AD mouse models, m6A levels increased in the cortex and hippocampus, and the expressions of Mettl3 and Fto increased and decreased, respectively, compared with control mice [48].